Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel

Kiyoshi Nakagawa1, Vijaykumar R Holla, Yuan Wei

  • 1Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.

Insights

Disrupting the cytochrome P450 4a10 (Cyp4a10) gene causes salt-sensitive hypertension in mice. This hypertension is linked to kidney sodium channel dysfunction, offering new insights into managing human hypertension.

Area of Science:

  • Biochemistry
  • Physiology
  • Genetics

Background:

  • Hypertension is a major cause of cardiovascular, cerebral, and renal disease.
  • Cytochrome P450 arachidonate monooxygenases are implicated in hypertension pathophysiology.
  • Dietary salt intake is a key factor in blood pressure regulation.

Purpose of the Study:

  • To investigate the role of cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10) in hypertension.
  • To determine the effect of Cyp4a10 gene disruption on blood pressure regulation.
  • To explore the link between Cyp4a10, kidney sodium channels, and salt sensitivity.

Main Methods:

  • Gene disruption of Cyp4a10 in mice (Cyp4a10-/-).
  • Dietary salt manipulation (low, normal, high salt diets).
  • Assessment of blood pressure and kidney epithelial sodium channel function.
  • Pharmacological intervention with amiloride.

Main Results:

  • Cyp4a10-/- mice developed salt-sensitive hypertension.
  • Hypertension was observed on normal and high-salt diets, but not low-salt diets.
  • Dysfunctional kidney epithelial sodium channels were identified in hypertensive Cyp4a10-/- mice.
  • Amiloride administration normalized blood pressure in hypertensive mice.

Conclusions:

  • The Cyp4a10 gene plays a crucial role in renal sodium reabsorption and blood pressure regulation.
  • A dysfunctional Cyp4a10 gene alters kidney epithelial sodium channel gating activity.
  • These findings suggest novel strategies for diagnosing and managing human hypertension.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...